Raimedita - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 22,168 | 25,331 | 20,212 | 24,567 | 31,324 | 30,755 | 29,366 | 25,490 |
| Profit before tax | - | - | - | - | - | - | - | - |
| Net profit | 1,509 | 1,319 | 2,701 | 2,786 | 5,238 | 3,792 | 6,734 | 196 |
| Equity | 8,332 | 7,650 | 10,352 | 13,137 | 18,375 | 22,168 | 28,901 | 29,096 |
| Liabilities | 363 | 900 | 1,304 | 1,271 | 2,654 | 1,350 | 1,524 | 1,480 |
| Non-current assets | 7,239 | 5,811 | 4,937 | 3,301 | 1,665 | 2,466 | 1,753 | 2,617 |
| Current assets | 1,456 | 2,710 | 6,719 | 11,107 | 19,364 | 21,052 | 28,672 | 27,959 |
| Total assets | 8,695 | 8,521 | 11,656 | 14,408 | 21,029 | 23,518 | 30,425 | 30,576 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 2,745 | 2,733 | 2,973 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +18.2% | +14.3% | -20.2% | +21.5% | +27.5% | -1.8% | -4.5% | -13.2% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 17.4% | 15.5% | 23.2% | 19.3% | 24.9% | 16.1% | 22.1% | 0.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 18.1% | 17.2% | 26.1% | 21.2% | 28.5% | 17.1% | 23.3% | 0.7% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 6.8% | 5.2% | 13.4% | 11.3% | 16.7% | 12.3% | 22.9% | 0.8% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 6,821 | 8,444 | 6,737 | 8,189 | 10,441 | 10,252 | 9,789 | 8,497 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Raimedita - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2023-09-18 | 2023-09-24 | 14.14 |
| 2022-09-16 | 2022-09-20 | 6.57 |
Raimedita - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2024-06-20 | 2025-05-07 | 0.1 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Raimedita, UAB (code 303377269) is a Private Limited Liability Company operating in dental practice care activities. In 2025, the company generated EUR 25.5K in revenue, down 13.2% year on year and 17.1% over two years. Net profit fell to EUR 196, after EUR 6.7K in 2024 and EUR 3.8K in 2023, reducing the profit margin to 0.8% from 22.9% in 2024 and 12.3% in 2023. The balance sheet remained stable, with total assets of EUR 30.6K, equity of EUR 29.1K and liabilities of EUR 1.5K. The equity ratio was 95.2% and debt-to-equity 0.05, indicating very limited leverage. Asset turnover stood at 0.83x, while ROE was 0.7% and ROA 0.6%. Revenue per employee was EUR 8.5K and profit per employee EUR 65, pointing to modest productivity in the latest year. Overall, 2025 was a weaker year for earnings, despite a strong equity base and low debt.